Annual CFI
-$53.30 M
+$33.55 M+38.63%
31 December 2023
Summary:
Atai Life Sciences NV annual cash flow from investing activities is currently -$53.30 million, with the most recent change of +$33.55 million (+38.63%) on 31 December 2023. During the last 3 years, it has fallen by -$25.02 million (-88.51%). ATAI annual CFI is now -129.32% below its all-time high of $181.79 million, reached on 01 December 2018.ATAI Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$24.84 M
+$8.54 M+52.38%
30 September 2024
Summary:
Atai Life Sciences NV quarterly cash flow from investing activities is currently $24.84 million, with the most recent change of +$8.54 million (+52.38%) on 30 September 2024. Over the past year, it has increased by +$71.33 million (+153.44%). ATAI quarterly CFI is now -68.97% below its all-time high of $80.05 million, reached on 31 December 2022.ATAI Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$51.79 M
+$71.33 M+365.10%
30 September 2024
Summary:
Atai Life Sciences NV TTM cash flow from investing activities is currently $51.79 million, with the most recent change of +$71.33 million (+365.10%) on 30 September 2024. Over the past year, it has increased by +$24.21 million (+87.78%). ATAI TTM CFI is now -64.01% below its all-time high of $143.91 million, reached on 31 March 2023.ATAI TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ATAI Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.6% | +153.4% | +87.8% |
| 3 y3 years | -88.5% | +4145.6% | +241.8% |
| 5 y5 years | -129.3% | - | - |
ATAI Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -88.5% | +38.6% | -69.0% | +111.6% | -64.0% | +117.7% |
| 5 y | 5 years | -129.3% | +38.6% | -69.0% | +111.6% | -64.0% | +117.7% |
| alltime | all time | -129.3% | +38.6% | -69.0% | +111.6% | -64.0% | +117.7% |
Atai Life Sciences NV Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $24.84 M(+52.4%) | $51.79 M(-365.1%) |
| June 2024 | - | $16.30 M(+42.1%) | -$19.54 M(-66.2%) |
| Mar 2024 | - | $11.47 M(-1493.8%) | -$57.84 M(+8.5%) |
| Dec 2023 | -$53.30 M(-38.6%) | -$823.00 K(-98.2%) | -$53.30 M(-293.2%) |
| Sept 2023 | - | -$46.48 M(+111.2%) | $27.58 M(-80.3%) |
| June 2023 | - | -$22.00 M(-237.4%) | $140.12 M(-2.6%) |
| Mar 2023 | - | $16.02 M(-80.0%) | $143.91 M(-265.7%) |
| Dec 2022 | -$86.85 M(+6.9%) | $80.05 M(+21.2%) | -$86.85 M(-59.7%) |
| Sept 2022 | - | $66.05 M(-462.6%) | -$215.53 M(-23.6%) |
| June 2022 | - | -$18.21 M(-91.5%) | -$282.20 M(-3.5%) |
| Mar 2022 | - | -$214.74 M(+341.5%) | -$292.29 M(+259.6%) |
| Dec 2021 | -$81.28 M(+187.5%) | -$48.63 M(+7820.7%) | -$81.28 M(+122.6%) |
| Sept 2021 | - | -$614.00 K(-97.8%) | -$36.51 M(-11.5%) |
| June 2021 | - | -$28.31 M(+660.8%) | -$41.27 M(+211.0%) |
| Mar 2021 | - | -$3.72 M(-3.8%) | -$13.27 M(-53.1%) |
| Dec 2020 | -$28.27 M | -$3.87 M(-28.1%) | -$28.27 M(+15.8%) |
| Sept 2020 | - | -$5.38 M(+1656.9%) | -$24.41 M(+28.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | -$306.00 K(-98.4%) | -$19.03 M(+1.6%) |
| Mar 2020 | - | -$18.72 M | -$18.72 M |
| Dec 2019 | -$9.03 M(-105.0%) | - | - |
| Dec 2018 | $181.79 M(-6052.2%) | - | - |
| Dec 2017 | -$3.05 M(-78.1%) | - | - |
| Mar 2017 | -$13.93 M(+140.7%) | - | - |
| Mar 2016 | -$5.79 M(-32.0%) | - | - |
| Mar 2015 | -$8.51 M(+273.1%) | - | - |
| Mar 2014 | -$2.28 M(+80.3%) | - | - |
| Mar 2013 | -$1.27 M(+51.5%) | - | - |
| Mar 2012 | -$835.20 K(+44.9%) | - | - |
| Mar 2011 | -$576.30 K(-93.6%) | - | - |
| Mar 2010 | -$9.04 M(+76.8%) | - | - |
| Mar 2009 | -$5.11 M(+644.8%) | - | - |
| Mar 2008 | -$686.20 K(-614.4%) | - | - |
| Mar 2007 | $133.40 K(-91.1%) | - | - |
| Mar 2006 | $1.50 M | - | - |
FAQ
- What is Atai Life Sciences NV annual cash flow from investing activities?
- What is the all time high annual CFI for Atai Life Sciences NV?
- What is Atai Life Sciences NV annual CFI year-on-year change?
- What is Atai Life Sciences NV quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Atai Life Sciences NV?
- What is Atai Life Sciences NV quarterly CFI year-on-year change?
- What is Atai Life Sciences NV TTM cash flow from investing activities?
- What is the all time high TTM CFI for Atai Life Sciences NV?
- What is Atai Life Sciences NV TTM CFI year-on-year change?
What is Atai Life Sciences NV annual cash flow from investing activities?
The current annual CFI of ATAI is -$53.30 M
What is the all time high annual CFI for Atai Life Sciences NV?
Atai Life Sciences NV all-time high annual cash flow from investing activities is $181.79 M
What is Atai Life Sciences NV annual CFI year-on-year change?
Over the past year, ATAI annual cash flow from investing activities has changed by +$33.55 M (+38.63%)
What is Atai Life Sciences NV quarterly cash flow from investing activities?
The current quarterly CFI of ATAI is $24.84 M
What is the all time high quarterly CFI for Atai Life Sciences NV?
Atai Life Sciences NV all-time high quarterly cash flow from investing activities is $80.05 M
What is Atai Life Sciences NV quarterly CFI year-on-year change?
Over the past year, ATAI quarterly cash flow from investing activities has changed by +$71.33 M (+153.44%)
What is Atai Life Sciences NV TTM cash flow from investing activities?
The current TTM CFI of ATAI is $51.79 M
What is the all time high TTM CFI for Atai Life Sciences NV?
Atai Life Sciences NV all-time high TTM cash flow from investing activities is $143.91 M
What is Atai Life Sciences NV TTM CFI year-on-year change?
Over the past year, ATAI TTM cash flow from investing activities has changed by +$24.21 M (+87.78%)